Career history of Caroline Roussel-Maupetit
Former positions of Caroline Roussel-Maupetit
| Companies | Position | Start | End |
|---|---|---|---|
| ADVICENNE | Chief Operating Officer | 2006-12-31 | 2020-03-11 |
| Founder | 2006-12-31 | 2020-03-11 | |
Synt:em SA
 Synt:em SA Pharmaceuticals: MajorHealth Technology Synt:em SA researches and manufactures drugs for the treatment of pain and cancer. The company specializes in the discovery and development of Central Nervous System (CNS) medicines and novel therapeutics for the treatment diseases. It was founded in 1995 by Michel Kaczorek and Caroline Roussel and is headquartered in Nîmes, France. | Chief Operating Officer | 1994-12-31 | 2004-12-31 |
| Founder | 1994-12-31 | 2004-12-31 | |
Proteine Performance
 Proteine Performance Medical SpecialtiesHealth Technology Part of Cystar, Proteine Performance is a French company that manufactures diagnostic products. The company is based in Paris, France. Proteine Performance was acquired by Cystar on September 01, 1995 for $6.27 million. | Sales & Marketing | - | - |
Training of Caroline Roussel-Maupetit
| Université de Technologie de Compiègne | Undergraduate Degree |
Statistics
International
| France | 5 |
Operational
| Chief Operating Officer | 2 |
| Founder | 2 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ADVICENNE | Health Technology |
| Private companies | 2 |
|---|---|
Proteine Performance
Proteine Performance Medical SpecialtiesHealth Technology Part of Cystar, Proteine Performance is a French company that manufactures diagnostic products. The company is based in Paris, France. Proteine Performance was acquired by Cystar on September 01, 1995 for $6.27 million. | Health Technology |
Synt:em SA
Synt:em SA Pharmaceuticals: MajorHealth Technology Synt:em SA researches and manufactures drugs for the treatment of pain and cancer. The company specializes in the discovery and development of Central Nervous System (CNS) medicines and novel therapeutics for the treatment diseases. It was founded in 1995 by Michel Kaczorek and Caroline Roussel and is headquartered in Nîmes, France. | Health Technology |
